Rapidly Advancing a Pipeline of Precision Medicines for the Brain
Our drugs target core brain processes, with the goal of improving these functions along with improving symptoms.
Cognition
Cognition
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
Emotion and its Regulation
Emotion and its Regulation
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Sleep and Activity
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Sleep and Activity
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Cognition
Cognition
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
Emotion and its Regulation
Emotion and its Regulation
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia)
Sleep and Activity
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Sleep and Activity
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms
PRODUCT CANDIDATE
(TARGET)
ALTO-100
(BDNF)
MDD, PTSD, Bipolar Depression
100'S SERIES NOVEL COMBINATIONS
100 SERIES
(C-AMP PATHWAY)
100 SERIES - 3 NOVEL COMBINATIONS
100 SERIES
(C-AMP PATHWAY)
200'S SERIES NOVEL COMBINATIONS
200 SERIES
(DOPAMINE PATHWAY)
Neuropsychiatric, Neurodegenerative
200 SERIES - 3 NOVEL COMBINATIONS
200 SERIES
(DOPAMINE PATHWAY)
Neuropsychiatric, Neurodegenerative
Cognition Pathway Targeting
Emotion Pathway Targeting
Receive updates from Alto
© Alto Neuroscience 2024